4//SEC Filing
CORRIGAN MARK 4
Accession 0001104659-21-098423
CIK 0001641640other
Filed
Jul 29, 8:00 PM ET
Accepted
Jul 30, 8:18 PM ET
Size
7.2 KB
Accession
0001104659-21-098423
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Share Options
2021-07-28−35,000→ 35,000 totalExercise: $1.08Exp: 2031-07-27→ Ordinary Shares (35,000 underlying) - Award
Ordinary Shares
2021-07-28+17,500→ 17,500 total
Footnotes (3)
- [F1]The reported transaction involved the reporting person's receipt of a grant of 17,500 restricted stock units. The total reported in Column 5 includes the 17,500 newly awarded restricted stock units.
- [F2]The option was granted on July 28, 2021.
- [F3]One hundred percent (100%) of the option will vest on July 31, 2022, subject to the reporting person's continued service on the board of directors of Nabriva Therapeutics plc.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001250661
Filing Metadata
- Form type
- 4
- Filed
- Jul 29, 8:00 PM ET
- Accepted
- Jul 30, 8:18 PM ET
- Size
- 7.2 KB